A la carte: BIOGEN CEO: Keeping Priority on the Biggest Diseases (WMIF)

Biogen CEO Michel Vounatsos will discuss how Biogen is tackling some of society’s most devastating neurological and neurodegenerative disorders, and share his perspective on the impact the global COVID-19 pandemic is having on the biopharmaceutical industry. Moderator: Jean-François Formela, MD, Partner, Atlas Venture Michel Vounatsos, CEO, Biogen

Not Enrolled

Course Includes

  • 1 Lesson